Apotex Bags First Biosimilar Neulasta, Plans To Undercut Amgen In Canada By 25%

 
• By Ian Schofield
  
Approved
Apotex has received approval in Canada for its biosimilar pegfilgrastim
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products